A new trading day began on Friday, with Tenaya Therapeutics Inc (NASDAQ: TNYA) stock price up 1.96% from the previous day of trading, before settling in for the closing price of $0.51. TNYA’s price has ranged from $0.39 to $4.96 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 45.89%. With a float of $134.13 million, this company’s outstanding shares have now reached $162.63 million.
Let’s look at the performance matrix of the company that is accounted for 97 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Tenaya Therapeutics Inc (TNYA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tenaya Therapeutics Inc is 17.52%, while institutional ownership is 20.45%. The most recent insider transaction that took place on Mar 10 ’25, was worth 1,336. In this transaction SVP, Finance of this company sold 2,482 shares at a rate of $0.54, taking the stock ownership to the 99,690 shares. Before that another transaction happened on Mar 10 ’25, when Company’s Chief Medical Officer sold 7,398 for $0.54, making the entire transaction worth $3,983. This insider now owns 174,793 shares in total.
Tenaya Therapeutics Inc (TNYA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 45.89% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Here are Tenaya Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.31, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Tenaya Therapeutics Inc (NASDAQ: TNYA) saw its 5-day average volume 1.74 million, a negative change from its year-to-date volume of 3.02 million. As of the previous 9 days, the stock’s Stochastic %D was 65.89%. Additionally, its Average True Range was 0.05.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 3.48%, which indicates a significant decrease from 85.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.12% in the past 14 days, which was lower than the 195.87% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6086, while its 200-day Moving Average is $1.7944. Nevertheless, the first resistance level for the watch stands at $0.5355 in the near term. At $0.5511, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5712. If the price goes on to break the first support level at $0.4998, it is likely to go to the next support level at $0.4797. Assuming the price breaks the second support level, the third support level stands at $0.4641.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
With a market capitalization of 84.57 million, the company has a total of 87,583K Shares Outstanding. Currently, annual sales are 0 K while annual income is -111,130 K. The company’s previous quarter sales were 0 K while its latest quarter income was -23,840 K.
